Safety evidence deserves particular scrutiny when adult data are applied to children,” says Christina Sheil, MD.
Some of the most widely used biologic medicines in oncology have patents about to expire, opening the market to noninnovative versions of these drugs. There are already many examples of price ...
After waiting over a year to hear what the Fourth Circuit would say about statistical sampling in False Claims Act cases, the court of appeals recently chose to keep ...